NO822255L - Fremgangsmaate for fremstilling av terapeutisk aktive sulfimin-derivater. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive sulfimin-derivater.Info
- Publication number
- NO822255L NO822255L NO822255A NO822255A NO822255L NO 822255 L NO822255 L NO 822255L NO 822255 A NO822255 A NO 822255A NO 822255 A NO822255 A NO 822255A NO 822255 L NO822255 L NO 822255L
- Authority
- NO
- Norway
- Prior art keywords
- butoxy
- group
- general formula
- theoretical
- yield
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19813129444 DE3129444A1 (de) | 1981-07-25 | 1981-07-25 | "sulfoximine, deren herstellung und diese verbindungen enthaltende arzneimittel" |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO822255L true NO822255L (no) | 1983-01-26 |
Family
ID=6137766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO822255A NO822255L (no) | 1981-07-25 | 1982-06-30 | Fremgangsmaate for fremstilling av terapeutisk aktive sulfimin-derivater. |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5824559A (enExample) |
| KR (1) | KR840000491A (enExample) |
| AR (1) | AR230745A1 (enExample) |
| AU (1) | AU556082B2 (enExample) |
| CA (1) | CA1175430A (enExample) |
| CS (1) | CS236488B2 (enExample) |
| DD (1) | DD202871A5 (enExample) |
| DE (2) | DE3129444A1 (enExample) |
| DK (1) | DK329582A (enExample) |
| ES (4) | ES8305333A1 (enExample) |
| FI (1) | FI822550A7 (enExample) |
| GR (1) | GR76181B (enExample) |
| HU (1) | HU188188B (enExample) |
| NO (1) | NO822255L (enExample) |
| PL (1) | PL137725B1 (enExample) |
| PT (1) | PT75297A (enExample) |
| SU (1) | SU1158041A3 (enExample) |
| YU (1) | YU158182A (enExample) |
| ZA (1) | ZA825273B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2247579B1 (en) * | 2008-01-17 | 2012-04-18 | Bayer Pharma Aktiengesellschaft | Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments |
-
1981
- 1981-07-25 DE DE19813129444 patent/DE3129444A1/de not_active Withdrawn
-
1982
- 1982-06-30 NO NO822255A patent/NO822255L/no unknown
- 1982-07-16 SU SU823463928A patent/SU1158041A3/ru active
- 1982-07-20 YU YU01581/82A patent/YU158182A/xx unknown
- 1982-07-20 FI FI822550A patent/FI822550A7/fi not_active Application Discontinuation
- 1982-07-21 AR AR290035A patent/AR230745A1/es active
- 1982-07-21 PL PL1982237600A patent/PL137725B1/pl unknown
- 1982-07-21 DD DD82241832A patent/DD202871A5/de unknown
- 1982-07-22 DK DK329582A patent/DK329582A/da not_active Application Discontinuation
- 1982-07-22 PT PT75297A patent/PT75297A/pt unknown
- 1982-07-22 CS CS825591A patent/CS236488B2/cs unknown
- 1982-07-22 HU HU822373A patent/HU188188B/hu unknown
- 1982-07-23 JP JP57128814A patent/JPS5824559A/ja active Pending
- 1982-07-23 ES ES514275A patent/ES8305333A1/es not_active Expired
- 1982-07-23 AU AU86378/82A patent/AU556082B2/en not_active Ceased
- 1982-07-23 GR GR68840A patent/GR76181B/el unknown
- 1982-07-23 ZA ZA825273A patent/ZA825273B/xx unknown
- 1982-07-23 CA CA000407915A patent/CA1175430A/en not_active Expired
- 1982-07-24 KR KR1019820003316A patent/KR840000491A/ko not_active Ceased
- 1982-12-18 DE DE19823246980 patent/DE3246980A1/de not_active Withdrawn
-
1983
- 1983-01-07 ES ES518826A patent/ES518826A0/es active Granted
- 1983-01-07 ES ES518828A patent/ES518828A0/es active Granted
- 1983-01-07 ES ES518827A patent/ES8400411A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE3246980A1 (de) | 1984-06-20 |
| AU556082B2 (en) | 1986-10-23 |
| DD202871A5 (de) | 1983-10-05 |
| SU1158041A3 (ru) | 1985-05-23 |
| ES518827A0 (es) | 1983-10-16 |
| FI822550L (fi) | 1983-01-26 |
| PL237600A1 (en) | 1983-03-28 |
| CS236488B2 (en) | 1985-05-15 |
| PL137725B1 (en) | 1986-07-31 |
| DE3129444A1 (de) | 1983-02-10 |
| ES8400412A1 (es) | 1983-10-16 |
| JPS5824559A (ja) | 1983-02-14 |
| KR840000491A (ko) | 1984-02-22 |
| ES8400410A1 (es) | 1983-10-16 |
| ES518828A0 (es) | 1983-10-16 |
| ES518826A0 (es) | 1983-10-16 |
| AU8637882A (en) | 1983-04-14 |
| CA1175430A (en) | 1984-10-02 |
| PT75297A (fr) | 1982-08-01 |
| ZA825273B (en) | 1984-03-28 |
| ES514275A0 (es) | 1983-04-01 |
| ES8400411A1 (es) | 1983-10-16 |
| YU158182A (en) | 1984-08-31 |
| FI822550A0 (fi) | 1982-07-20 |
| HU188188B (en) | 1986-03-28 |
| ES8305333A1 (es) | 1983-04-01 |
| GR76181B (enExample) | 1984-08-03 |
| AR230745A1 (es) | 1984-06-29 |
| FI822550A7 (fi) | 1983-01-26 |
| DK329582A (da) | 1983-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO860918L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonylaminoetylforbindelser. | |
| NO165237B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonamido-indanylforbindelser. | |
| NO178695B (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive sulfonamider | |
| US4698344A (en) | 1-Heteroaryl-4-aryl-pyrazolin-5-ones for use as medicaments | |
| NO177300B (no) | Analogifremgangsmåte for fremstilling av et kinolinderivat og mellomprodukter | |
| CZ300570B6 (cs) | Inhibitory biosyntézy prostaglandin endoperoxid H synthasy | |
| KR20000022437A (ko) | 신규 아미디노 유도체 및 트롬빈 억제제로서의 그의 용도 | |
| US20030050310A1 (en) | Hydroxamic acid derivatives as proteinase inhibitors | |
| US4148801A (en) | 3-[(Chlorophenylsulfonyl)methyl]-1,2,4-oxadiazole-5-carboxylic acid derivatives | |
| NO158738B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazin-2-on-derivater. | |
| JP2790926B2 (ja) | スルホンアミド誘導体 | |
| CA2494616A1 (en) | Furanthiazole derivatives as heparanase inhibitors | |
| KR102047816B1 (ko) | 염증 및 암 치료에 유용한 비스아릴술폰아미드 | |
| NO822255L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive sulfimin-derivater. | |
| KR880002227B1 (ko) | 인돌리논의 제조방법 | |
| NO142403B (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive isokinoliner | |
| US4551464A (en) | Antithrombotic sulfoximino carbostyrils | |
| NO152843B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidopyrimidiner | |
| NO142524B (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive cykloheksylfenyl-derivater | |
| AU2006293867A1 (en) | Sulphonamide derivatives | |
| US3816424A (en) | Benzenesulfonamidopyrimidines | |
| EP0145304B1 (en) | Tetrahydro-beta-carboline derivatives and process for the preparation thereof | |
| NO792510L (no) | Fremgangsmaate ved fremstilling av oxadiazolotriazin-derivater | |
| SU1685934A1 (ru) | Натриева соль 2-(2,6-диметил-3,5-диэтоксикарбонил-1,4-дигидропиридин-4-карбоксамидо)этансульфокислоты, обладающа антиагрегационной активностью | |
| NO132094B (enExample) |